Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Rossing

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Journal of Molecular Endocrinology|November 4, 2011
Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinomaMaria Rossing, Rehannah Borup, Ricardo Henao, et al.
European Heart Journal. Acute Cardiovascular Care|June 13, 2022
MicroRNA-9-3p: a novel predictor of neurological outcome after cardiac arrestRasmus Paulin Beske, Søren Bache, Martin Abild Stengaard Meyer, et al.
Frontiers in Endocrinology|May 16, 2020
Variability in Medullary Thyroid Carcinoma in <i>RET</i> L790F Carriers: A Case Comparison Study of Index PatientsJes Sloth Mathiesen, Søren Grønlund Nielsen, Åse Krogh Rasmussen, et al.
The Journal of Clinical Investigation|May 8, 2020
Germline RBBP8 variants associated with early-onset breast cancer compromise replication fork stabilityReihaneh Zarrizi, Martin R Higgs, Karolin Voßgröne, et al.
Journal of Neuroendocrinology|August 11, 2023
Imaging surveillance in multiple endocrine neoplasia type 1: Ten years of experience with somatostatin receptor positron emission tomographyMaha Said, Jesper Krogh, Ulla Feldt-Rasmussen, et al.
Breast Cancer Research and Treatment|May 23, 2025
Timely germline BRCA testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective studyAleksandar M Kostov, Maj-Britt Jensen, Bent Ejlertsen, et al.
BMC Cancer|August 7, 2025
Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid TumorsKristian Egebjerg, Iben Spanggaard, Lise Barlebo Ahlborn, et al.
Cold Spring Harbor Molecular Case Studies|April 15, 2022
9p21.3 Microdeletion involving <i>CDKN2A/2B</i> in a young patient with multiple primary cancers and review of the literatureMarlene Richter Jensen, Ulrik Stoltze, Thomas Van Overeem Hansen, et al.
Frontiers in Pediatrics|May 8, 2018
Importance of Comprehensive Molecular Profiling for Clinical Outcome in Children With Recurrent CancerOlga Østrup, Karsten Nysom, David Scheie, et al.
Thyroid : Official Journal of the American Thyroid Association|October 13, 2017
Founder Effect of the RET<sup>C611Y</sup> Mutation in Multiple Endocrine Neoplasia 2A in Denmark: A Nationwide StudyJes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Journal of Molecular Endocrinology|November 4, 2011
Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinomaMaria Rossing, Rehannah Borup, Ricardo Henao, et al.
European Heart Journal. Acute Cardiovascular Care|June 13, 2022
MicroRNA-9-3p: a novel predictor of neurological outcome after cardiac arrestRasmus Paulin Beske, Søren Bache, Martin Abild Stengaard Meyer, et al.
Frontiers in Endocrinology|May 16, 2020
Variability in Medullary Thyroid Carcinoma in <i>RET</i> L790F Carriers: A Case Comparison Study of Index PatientsJes Sloth Mathiesen, Søren Grønlund Nielsen, Åse Krogh Rasmussen, et al.
The Journal of Clinical Investigation|May 8, 2020
Germline RBBP8 variants associated with early-onset breast cancer compromise replication fork stabilityReihaneh Zarrizi, Martin R Higgs, Karolin Voßgröne, et al.
Journal of Neuroendocrinology|August 11, 2023
Imaging surveillance in multiple endocrine neoplasia type 1: Ten years of experience with somatostatin receptor positron emission tomographyMaha Said, Jesper Krogh, Ulla Feldt-Rasmussen, et al.
Breast Cancer Research and Treatment|May 23, 2025
Timely germline BRCA testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective studyAleksandar M Kostov, Maj-Britt Jensen, Bent Ejlertsen, et al.
BMC Cancer|August 7, 2025
Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid TumorsKristian Egebjerg, Iben Spanggaard, Lise Barlebo Ahlborn, et al.
Cold Spring Harbor Molecular Case Studies|April 15, 2022
9p21.3 Microdeletion involving <i>CDKN2A/2B</i> in a young patient with multiple primary cancers and review of the literatureMarlene Richter Jensen, Ulrik Stoltze, Thomas Van Overeem Hansen, et al.
Frontiers in Pediatrics|May 8, 2018
Importance of Comprehensive Molecular Profiling for Clinical Outcome in Children With Recurrent CancerOlga Østrup, Karsten Nysom, David Scheie, et al.
Thyroid : Official Journal of the American Thyroid Association|October 13, 2017
Founder Effect of the RET<sup>C611Y</sup> Mutation in Multiple Endocrine Neoplasia 2A in Denmark: A Nationwide StudyJes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, et al.
Pageof 13